MedTrace Logo

Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH

NCT04245566 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 425

Last updated 2021-01-26

No results posted yet for this study

Summary

This study compares safety and efficacy of prostatic artery embolization and pharmacotherapy in the treatment of lower urinary tract symptoms associated wit benign prostatic hyperplasia.

Conditions

  • Benign Prostatic Hyperplasia
  • Pharmacotherapy
  • Prostatic Artery Embolization
  • Minimally Invasive Treatment

Interventions

PROCEDURE

Prostatic Artery Embolization (PAE)

Prostatic artery embolization will be performed under local anesthesia according to well established and standardized techniques.

DRUG

Pharmacotherapy

Pharmacotherapy will be performed using α1-blockers and 5α-reductase inhibitors in accordance with the EAU recommendations

Sponsors & Collaborators

  • Dominik Abt

    lead OTHER

Principal Investigators

  • Dominik Abt, MD · Cantonal Hospital St. Gallen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-12-31
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245566 on ClinicalTrials.gov